216 related articles for article (PubMed ID: 6445226)
1. Role of suppressor cells in depression of T lymphocyte proliferative response in untreated and treated Hodgkin's disease.
Han T
Cancer; 1980 Apr; 45(8):2102-8. PubMed ID: 6445226
[TBL] [Abstract][Full Text] [Related]
2. Splenic T and B lymphocytes and their mitogenic response in untreated Hodgkin's disease.
Han T; Minowada J; Subramanian V; Barcos M; Kim U
Cancer; 1980 Feb; 45(4):767-74. PubMed ID: 6965606
[TBL] [Abstract][Full Text] [Related]
3. Impaired cell-mediated immunity in Hodgkin's disease mediated by suppressor lymphocytes and monocytes.
Hillinger SM; Herzig GP
J Clin Invest; 1978 Jun; 61(6):1620-7. PubMed ID: 149140
[TBL] [Abstract][Full Text] [Related]
4. Impaired interleukin regulation of the phytohemagglutinin response in Hodgkin's disease.
Zamkoff KW; Reeves WG; Paolozzi FP; Poiesz BJ; Comis RL; Tomar RH
Clin Immunol Immunopathol; 1985 Apr; 35(1):111-24. PubMed ID: 3922653
[TBL] [Abstract][Full Text] [Related]
5. Depressed T cell proliferative responses in Hodgkin's disease: role of monocyte-mediated suppression via prostaglandins and hydrogen peroxide.
Fisher RI; Bostick-Bruton F
J Immunol; 1982 Oct; 129(4):1770-4. PubMed ID: 6980949
[TBL] [Abstract][Full Text] [Related]
6. Monocyte-dependent serum suppression of lymphocyte blastogenesis in Hodgkin's disease: an association with nephrotic syndrome.
Crowley JP; Ree HJ; Esparza A
J Clin Immunol; 1982 Oct; 2(4):270-5. PubMed ID: 6216262
[TBL] [Abstract][Full Text] [Related]
7. Monocyte function in Hodgkin's disease.
Holm G; Björkholm M; Johansson B; Mellstedt H; Lindemalm C
Clin Exp Immunol; 1982 Jan; 47(1):162-8. PubMed ID: 7094420
[TBL] [Abstract][Full Text] [Related]
8. Abnormalities of in vitro immunoglobulin synthesis by peripheral blood lymphocytes from untreated patients with Hodgkin's disease.
Romagnani S; Del Prete GF; Maggi E; Bellesi G; Biti G; Rossi Ferrini PL; Ricci M
J Clin Invest; 1983 May; 71(5):1375-82. PubMed ID: 6602150
[TBL] [Abstract][Full Text] [Related]
9. Functional activities of enriched Fc receptor bearing T lymphocytes in Hodgkin's disease.
Gulwani BN; Advani SH; Gangal SG
Oncology; 1986; 43(3):159-64. PubMed ID: 2939383
[TBL] [Abstract][Full Text] [Related]
10. Evidence for the involvement of monocyte-derived toxic oxygen metabolites in the lymphocyte dysfunction of Hodgkin's disease.
Deshazo RD; Ewel C; Londono S; Metzger Z; Hoffeld JT; Oppenheim JJ
Clin Exp Immunol; 1981 Nov; 46(2):313-20. PubMed ID: 7337972
[TBL] [Abstract][Full Text] [Related]
11. Impaired lymphocyte transformation in Hodgkin's disease. Evidence for depletion of circulating t-lymphocytes.
Matchett KM; Huang AT; Kremer WB
J Clin Invest; 1973 Aug; 52(8):1908-17. PubMed ID: 4541673
[TBL] [Abstract][Full Text] [Related]
12. Increased sensitivity of T cells to regulation by normal suppressor cells persists in long-term survivors with Hodgkin's disease.
Vanhaelen CP; Fisher RI
Am J Med; 1982 Mar; 72(3):385-90. PubMed ID: 6460444
[TBL] [Abstract][Full Text] [Related]
13. Diminished autologous mixed lymphocyte reaction in patients with Hodgkin disease: evidence for non-T cell dysfunction.
Zamkoff KW; Dock NL; Kurec AS; Davey FR
Am J Hematol; 1982 Jun; 12(4):327-35. PubMed ID: 6214184
[TBL] [Abstract][Full Text] [Related]
14. Hyperproduction of IgE and T-cell dysfunction in Hodgkin's disease.
Romagnani S; Biagiotti R; Amadori A; Maggi E; Biti G; Bellesi G; Ricci M
Int Arch Allergy Appl Immunol; 1980; 63(1):64-72. PubMed ID: 6967458
[TBL] [Abstract][Full Text] [Related]
15. In vitro lymphocyte dysfunction in Hodgkin's disease.
Graze PR; Perlin E; Royston I
J Natl Cancer Inst; 1976 Feb; 56(2):239-43. PubMed ID: 130496
[TBL] [Abstract][Full Text] [Related]
16. Alterations of peripheral blood lymphocyte cyclic AMP and cyclic GMP in untreated patients with hodgkin's disease.
Aleksijevic A; Lang JM; Giron C; Stoclet JC; Mayer S; Oberling F
Clin Immunol Immunopathol; 1983 Mar; 26(3):398-405. PubMed ID: 6307567
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical analysis of the distribution of lymphocyte subpopulations in Hodgkin's disease.
Borowitz MJ; Croker BP; Metzgar RS
Cancer Treat Rep; 1982 Apr; 66(4):667-74. PubMed ID: 6210433
[TBL] [Abstract][Full Text] [Related]
18. Spectrum of immunodeficiencies with Hodgkin's disease.
Twomey JJ; Laughter AH; Rice L; Ford R
J Clin Invest; 1980 Oct; 66(4):629-37. PubMed ID: 6448268
[TBL] [Abstract][Full Text] [Related]
19. Studies on lymphocyte hyporesponsiveness in cirrhosis: the role of increased monocyte suppressor cell activity.
Holdstock G; Chastenay BF; Krawitt EL
Gastroenterology; 1982 Feb; 82(2):206-12. PubMed ID: 6459260
[TBL] [Abstract][Full Text] [Related]
20. [Hodgkin's disease. T lymphocyte defect in patients in complete remission (author's transl)].
Lang JM; Bigel P; Oberling F; Mayer S
Pathol Biol (Paris); 1978; 26(3-4):159-62. PubMed ID: 355984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
